Drug
Skin Biopsy
Skin Biopsy: highest development phase Phase 2/3, developed by Endo. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2/3
- Developer
- Endo
Trials
| Drug | Phase | Indication |
|---|---|---|
| Skin biopsy NCT01086150 | Phase 2/3 | Diabetic Peripheral Neuropathy |
Latest
No recent events.
Follow Skin Biopsy on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.